USAID (US Agency for International Development) ploughs $6 million into African injection safety:
This article was originally published in Clinica
Executive Summary
The US Agency for International Development (USAID) has awarded $6m for projects to improve medical injection safety in six African countries. The aim of the funding, part of the US government's $15bn Emergency Plan for AIDS Relief, is to reduce the transmission of HIV - and other blood-borne diseases, such as hepatitis B and C - associated with "unsafe and sometimes unnecessary medical injections". The re-use of syringes and needles without sterilisation is at the heart of the problem, says USAID. The projects planned for Ethiopia, Mozambique, Namibia, Nigeria, Uganda and Zambia range from supply logistics management to healthcare waste disposal. More than 16 billion medical injections a year are administered in developing countries, the World Health Organization estimates.
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.